Torren Management
ANRO icon

Torren Management’s Alto Neuroscience ANRO Stock Holding History

Torren Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.4K Sell
409
-149
-27% -$4.48K 0.01% 216
2026
Q2 		$14.7K Hold
558
– – 0.01% 171
2026
Q1 		$12.5K Sell
558
-2,926
-84% -$54.2K 0.01% 170
2025
Q4 		$62K Buy
+3,484
New +$43.9K 0.03% 264

Other funds holding ANRO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
University of Texas/Texas AM Investment Management Co (UTIMCO)
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $798M AUM 22.92% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Torren Management's ANRO Position: Q3 2026 in Review

Torren Management reduced its Alto Neuroscience (ANRO) stake by 27% in Q3 2026, selling an estimated $4.48K and leaving 409 shares worth $10.4K. The position accounts for 0.01% of the portfolio, ranked #216.

Torren Management first reported a position in ANRO in Q4 2025 and has held it in 4 quarters since. The position peaked at $62K in Q4 2025. 31 funds tracked by Wall St. Rank hold ANRO as of Q3 2026.

  • Torren Management held 409 shares of Alto Neuroscience worth $10.4K as of Q3 2026.
  • Torren Management sold 149 Alto Neuroscience shares in Q3 2026, an estimated $4.48K.
  • Alto Neuroscience made up 0.01% of Torren Management's portfolio in Q3 2026, its #216 holding.
  • Torren Management first reported a position in Alto Neuroscience in Q4 2025 and has held it in 4 quarters since.
  • Torren Management's Alto Neuroscience position peaked at $62K in Q4 2025.
  • 31 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2026.

Based on Torren Management's 13F filing for Q3 2026, filed 29 Oct 2026.